Light-activated sunitinib causes endothelial and vascular damage leading to tumor growth inhibition

Nowak-Sliwinska, PatrycjaWeiss, AndreaVan Beijnum, Judy R.Szewczyk, GrzegorzSarna, TadeuszGriffioen, Arjan W.2014-08-292014-08-292014-08-292014https://infoscience.epfl.ch/handle/20.500.14299/106370WOS:000338213400171Light-activated sunitinib causes endothelial and vascular damage leading to tumor growth inhibitiontext::conference output::conference proceedings::conference paper